Company profile: Global Q
1.1 - Company Overview
Company description
- Provider of cloud-based quality management software and guided compliance with data and complaints management for manufacturers. Solutions include MediGPT for medical device and pharmaceutical firms to improve productivity, cost savings, speed to market and quality; Optiqs360 Digital applying intelligence across operations; IntelliWriter for one-click document automation; and customer success services.
Products and services
- IntelliWriter: A template-based automation tool that integrates enterprise data into templates for one-click document creation, accelerating documentation workflows and minimizing manual compilation
- MediGPT: An AI-driven platform for medical device and pharmaceutical manufacturers that boosts productivity, cost savings, speed to market, and product quality through applied intelligence
- Optiqs360 Digital: An enterprise-grade service that applies intelligence across enterprise operations to enhance productivity and improve decision-making, streamlining activities with data-driven guidance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Global Q
Immunai
HQ: United States
Website
- Description: Provider of immunology mapping and reprogramming solutions leveraging machine learning and software engineering, including AMICA—a comprehensive immune cell knowledge base integrating clinico-genomic data; single-cell analysis and functional genomics; and drug discovery and development support from target discovery and validation through compound validation and clinical trial optimization, with biopharma and academic partnerships contributing data back to AMICA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunai company profile →
Matrical
HQ: United States
Website
- Description: Provider of biological sample preparation, management and storage solutions, offering automated biobanking; sample storage systems from ambient to cryogenic; cryogenic storage and carriers; injection-molded microwell plates; a sample management LIMS for biobanking and cell lines; multiomics and synthesis (sequencing, proteomics); and sample storage, relocation and transportation with on-site management, risk mitigation and disaster recovery support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Matrical company profile →
Linaris
HQ: Germany
Website
- Description: Provider of a comprehensive product offering of antibodies, proteins, ELISA kits, and reagents from leading global manufacturers as a specialized distributor.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Linaris company profile →
Florence Healthcare
HQ: United States
Website
- Description: Provider of a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Florence Healthcare company profile →
Accutar Bio
HQ: China
Website
- Description: Provider of AI-driven drug discovery solutions, including ChemiRise for end-to-end retrosynthesis via a graph convolutional one-step reaction proposer; Chemi-Net for ADME prediction; targeted protein degradation (ER degraders for breast cancer, AR degraders for prostate cancer); an orbital docking platform from SMILES with conformational error detection; virtual screening validated by crystallization; and an AI platform for novel small molecule discovery for chronic inflammatory diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accutar Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Global Q
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Global Q
2.2 - Growth funds investing in similar companies to Global Q
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Global Q
4.2 - Public trading comparable groups for Global Q
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →